专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20130082821A1 PROXIMITY-BASED GLUCOSE METER FUNCTION ACTIVATION 审中-公开
标题翻译：基于接近度的葡萄糖测量仪功能激活
公开(公告)号：US20130082821A1
公开(公告)日：2013-04-04
申请号：US13252439
申请日：2011-10-04
申请人： Steven A. Bousamra , Ulrich Porsch , John F. Price
发明人： Steven A. Bousamra , Ulrich Porsch , John F. Price
IPC分类号： G08B29/00
CPC分类号： A61B5/14532 , A61B5/002 , A61B5/7405 , A61B2560/0209 , G08B21/22 , G16H40/63
摘要： A method and system in which a short range wireless signal containing an activation code is received with a glucose meter. Upon receiving the signal, the glucose meter awakens from a low power state. A dormant function on the glucose meter that corresponds to the activation code is activated in response to receiving the short range wireless signal. In one example, the glucose meter includes an RFID tag configured to receive an RFID signal. A device reader coupled to a health care provider computer transmits the RFID signal. The dormant function on the glucose meter can include any number of functions, such as a structured glucose test and/or the ability to automatically generate reports.
摘要翻译：一种方法和系统，其中使用葡萄糖计收到包含激活码的短距离无线信号。在接收到信号时，血糖仪从低功率状态唤醒。响应于接收短程无线信号，激活对应于激活码的葡萄糖计的休眠功能。在一个示例中，葡萄糖计包括被配置为接收RFID信号的RFID标签。耦合到医疗保健提供者计算机的设备读取器发送RFID信号。葡萄糖计的休眠功能可以包括任何数量的功能，例如结构化葡萄糖测试和/或自动产生报告的能力。

2. 发明申请

US20130212381A1 SYSTEM AND METHOD FOR CONTROLLING AUTHORIZED ACCESS TO A STRUCTURED TESTING PROCEDURE ON A MEDICAL DEVICE 审中-公开
标题翻译：用于控制被授权访问医疗设备上的结构化测试程序的系统和方法
公开(公告)号：US20130212381A1
公开(公告)日：2013-08-15
申请号：US13397241
申请日：2012-02-15
申请人： Steven A. Bousamra , Douglas M. Charboneau , Daniel J. DiSalvo , Alan M. Greenburg , Ulrich Porsch , John F. Price , Raymond A. Strickland , William T. Tucek , Stefan Weinert
发明人： Steven A. Bousamra , Douglas M. Charboneau , Daniel J. DiSalvo , Alan M. Greenburg , Ulrich Porsch , John F. Price , Raymond A. Strickland , William T. Tucek , Stefan Weinert
IPC分类号： G06F21/22
CPC分类号： G06F21/335 , G06F21/6218 , G06F21/629 , G06F2221/2105 , G06F2221/2141 , H04L63/0823 , H04L67/12 , H04L67/34
摘要： Methods and systems for authorizing access to a medical device are disclosed. The methods and systems use authorization certificates to allow and prevent access to one or more operations of the medical device. The methods and systems also allow the tracking of changes made to the medical device by an authorized user.
摘要翻译：公开了授权访问医疗设备的方法和系统。方法和系统使用授权证书来允许和阻止访问医疗设备的一个或多个操作。方法和系统还允许跟踪由授权用户对医疗设备进行的改变。

3. 发明申请

US20110015511A1 SYSTEMS AND METHODS FOR OPTIMIZING INSULIN DOSAGE 有权
标题翻译：用于优化胰岛素剂量的系统和方法
公开(公告)号：US20110015511A1
公开(公告)日：2011-01-20
申请号：US12818310
申请日：2010-06-18
申请人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
发明人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
IPC分类号： A61B5/145 , G06F19/00 , G01N33/48 , G09B23/28
CPC分类号： A61B5/0002 , A61B5/05 , A61B5/14532 , A61B5/14546 , A61M31/00 , A61M2230/201 , C12Q1/006 , G06F19/00 , G06F19/3418 , G06F19/3456 , G16H10/20 , G16H10/40 , G16H20/17 , G16H80/00
摘要： Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.
摘要翻译：适于糖尿病患者优化其施用的胰岛素剂量的测试方法的实施方案包括收集一个或多个生物标志物数据的采样组，其中每个采样组包括足够多个非不良采样实例，并且其中每个采样实例包括可接受的生物标志物读数在符合遵守标准的单个时间点上，从每个采样组确定生物标志物采样参数，将生物标志物采样参数与目标生物标志物范围进行比较，计算与生物标志物采样参数相关联的胰岛素调节参数，如果生物标志物采样参数如果生物标志物采样参数落在目标生物标志物范围之外，并且如果胰岛素剂量不超过最大剂量，并且如果调整的胰岛素剂量是最佳的则退出测试方法，则超出目标生物标志物范围，通过胰岛素调节参数调整胰岛素剂量 zed。当一个或多个生物标志物采样参数落入目标生物标志物范围内时，胰岛素剂量被优化。

4. 发明授权

US09918635B2 Systems and methods for optimizing insulin dosage 有权
公开(公告)号：US09918635B2
公开(公告)日：2018-03-20
申请号：US12818310
申请日：2010-06-18
申请人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
发明人： Steven Bousamra , Stefan Weinert , Juergen Rasch-Menges , P. Douglas Walling , John F. Price , Heino Eikmeier , Birgit Kraeling , Karl Werner , Ulrich Porsch
IPC分类号： A61B5/00 , A61B5/145 , G06F19/00 , A61M31/00 , A61B5/05 , C12Q1/00
CPC分类号： A61B5/0002 , A61B5/05 , A61B5/14532 , A61B5/14546 , A61M31/00 , A61M2230/201 , C12Q1/006 , G06F19/00 , G06F19/3418 , G06F19/3456 , G16H10/20 , G16H10/40 , G16H20/17 , G16H80/00
摘要： Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.

5. 发明申请

US20120266251A1 SYSTEMS AND METHODS FOR DISEASE MANAGEMENT 有权
标题翻译：疾病管理系统与方法
公开(公告)号：US20120266251A1
公开(公告)日：2012-10-18
申请号：US13267315
申请日：2011-10-06
申请人： Daniel Birtwhistle , Ulrich Porsch , John F. Price , Raymond Strickland
发明人： Daniel Birtwhistle , Ulrich Porsch , John F. Price , Raymond Strickland
IPC分类号： G06F21/00
CPC分类号： H04W12/08 , G06F19/00 , G06F19/3481 , G16H10/65 , H04W12/04 , H04W12/06
摘要： A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
摘要翻译：提供了一种计算机实现的糖尿病管理系统，其支持与医疗设备进行数据通信的糖尿病护理经理之间的增强的安全性。糖尿病护理管理器包括：第一应用，其操作以请求访问由医疗设备支持的第一安全角色，其中第一安全角色与用于访问医疗设备上的数据的第一组命令相关联，所述命令定义为通信协议的私有扩展; 以及第二应用，其操作以请求访问所述医疗设备支持的第二安全角色，其中所述第二安全角色与用于访问所述医疗设备上被定义为所述通信的私有扩展的第二组命令相关联协议。第二组命令具有与第一组命令相互排斥的一个或多个命令。

6. 发明授权

US08707392B2 Systems and methods for disease management 有权
标题翻译：疾病管理系统和方法
公开(公告)号：US08707392B2
公开(公告)日：2014-04-22
申请号：US13267315
申请日：2011-10-06
申请人： Daniel Birtwhistle , Ulrich Porsch , John F. Price , Raymond Strickland
发明人： Daniel Birtwhistle , Ulrich Porsch , John F. Price , Raymond Strickland
IPC分类号： H04L29/06
CPC分类号： H04W12/08 , G06F19/00 , G06F19/3481 , G16H10/65 , H04W12/04 , H04W12/06
摘要： A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
摘要翻译：提供了一种计算机实现的糖尿病管理系统，其支持与医疗设备进行数据通信的糖尿病护理经理之间的增强的安全性。糖尿病护理管理器包括：第一应用，其操作以请求访问由医疗设备支持的第一安全角色，其中第一安全角色与用于访问医疗设备上的数据的第一组命令相关联，所述命令定义为通信协议的私有扩展; 以及第二应用，其操作以请求访问所述医疗设备支持的第二安全角色，其中所述第二安全角色与用于访问所述医疗设备上被定义为所述通信的私有扩展的第二组命令相关联协议。第二组命令具有与第一组命令相互排斥的一个或多个命令。

7. 发明授权

US08667293B2 Cryptographic data distribution and revocation for handheld medical devices 有权
标题翻译：手持医疗设备的加密数据分发和撤销
公开(公告)号：US08667293B2
公开(公告)日：2014-03-04
申请号：US13207934
申请日：2011-08-11
申请人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
发明人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
IPC分类号： G06F21/00
CPC分类号： H04L63/0823 , G06F19/00 , G16H40/40 , H04L9/3268 , H04W12/08 , H04W88/02
摘要： A method includes: receiving a revocation list from a remote data server at a configuration device. The revocation list includes N cryptographic certificates associated with N computer software entities, respectively, that are not to be executed by any of a group of medical devices including a handheld medical device. N is an integer greater than or equal to zero The method further includes receiving data from the handheld medical device at the configuration device. The data includes a cryptographic certificate that is associated with a given computer software entity that is presently installed in memory of the handheld medical device for execution by the handheld medical device. The method further includes comparing the cryptographic certificate with the revocation list; and selectively executing a protective function by the configuration device when the cryptographic certificate is the same as one of the N cryptographic certificates of the revocation list.
摘要翻译：一种方法包括：在配置设备处从远程数据服务器接收撤销列表。撤销列表分别包括与N个计算机软件实体相关联的N个加密证书，其不被包括手持医疗设备的一组医疗设备中的任何一个执行。 N是大于或等于零的整数。该方法还包括在配置设备处从手持式医疗设备接收数据。数据包括与当前安装在手持式医疗设备的存储器中以由手持医疗设备执行的给定计算机软件实体相关联的加密证书。该方法还包括将加密证书与撤销列表进行比较; 并且当密码证书与撤销列表的N个密码证书中的一个相同时，由配置设备选择性地执行保护功能。

8. 发明申请

US20120269347A1 Medical device with secure data transmission 有权
标题翻译：具有安全数据传输的医疗设备
公开(公告)号：US20120269347A1
公开(公告)日：2012-10-25
申请号：US13434298
申请日：2012-03-29
申请人： Ulrich Porsch , Kai-Oliver Schwenker , Daniel Birtwhistle , Raymond Strickland , Max Moser , Thorsten Schroeder
发明人： Ulrich Porsch , Kai-Oliver Schwenker , Daniel Birtwhistle , Raymond Strickland , Max Moser , Thorsten Schroeder
IPC分类号： H04L9/00
CPC分类号： H04L63/0428 , H04L63/061 , H04L63/18 , H04L2463/061 , H04W72/02 , H04W76/10
摘要： Secure transmission of electronic data via a data communication link is provided between a device and an additional device with independent transmission channels, wherein at least one of the devices is a medical device. Secure transmission comprises the following steps or means: providing a password in the device, receiving the password in the a additional device separate from the data communication link, selecting one of the independent transmission channels, encrypting the channel identification of the selected independent transmission channel using the received password in the additional device, transmitting the encrypted channel identification from the additional device to the device via the data communication link and decrypting the encrypted channel identification in the device, providing a session key in the device and the additional device and transmitting encrypted electronic data between the device and the additional device via the independent transmission channel.
摘要翻译：在设备和具有独立传输信道的附加设备之间提供经由数据通信链路的电子数据的安全传输，其中至少一个设备是医疗设备。安全传输包括以下步骤或手段：在设备中提供密码，在与数据通信链路分离的附加设备中接收密码，选择独立传输信道中的一个，加密所选独立传输信道的信道标识，使用在附加设备中接收的密码，经由数据通信链路将加密的信道标识从附加设备发送到设备，并解密设备中的加密信道标识，在设备和附加设备中提供会话密钥，并发送加密电子通过独立传输通道在设备和附加设备之间的数据。

9. 发明申请

US20120094370A1 BLOOD GLUCOSE TEST INSTRUMENT KIT HAVING MODULAR COMPONENT PARTS 有权
标题翻译：具有模块化部件的血液葡萄糖测试仪器套件
公开(公告)号：US20120094370A1
公开(公告)日：2012-04-19
申请号：US12905485
申请日：2010-10-15
申请人： Blaine E. Ramey , Karl Werner , Richard W. Wilson , Christian Niesporek , Ralf Schmitz , Peter Seelig , Kai-Oliver Schwenker , Ulrich Porsch
发明人： Blaine E. Ramey , Karl Werner , Richard W. Wilson , Christian Niesporek , Ralf Schmitz , Peter Seelig , Kai-Oliver Schwenker , Ulrich Porsch
IPC分类号： C12M1/34
CPC分类号： A61B5/14532 , A61B5/150022 , A61B5/150305 , A61B5/150358 , A61B5/150854 , A61B5/150862 , A61B5/15087 , A61B5/150877 , A61B5/150961 , A61B5/155 , A61B5/157 , A61B5/4839 , A61B2560/0443 , A61B2560/045 , A61M5/1723 , G06F19/00 , G16H40/63
摘要： A blood glucose test instrument kit having modular component parts capable of being assembled into a plurality of different handheld blood glucose test instruments is disclosed. The kit comprises the combination of an interconnection platform adapted to connect to a collection of interoperable modules. The collection of interoperable modules including: a plurality of different measurement engine modules, at least one user interface module, at least one power supply module. A handheld blood glucose test instrument is assembled by the interconnection to the interconnection platform of at least one measurement engine module, at least one user interface module, and at least one power supply module. The inter-module communication among the modules connected thereto to achieve enhanced glucose test instrument reliability by effecting at least one reliability protocol selected from a group of reliability protocols.
摘要翻译：公开了具有能够组装成多个不同的手持式血糖测试仪器的模块化部件的血糖测试仪器套件。该套件包括适于连接到可互操作模块集合的互连平台的组合。可互操作模块的集合包括：多个不同的测量引擎模块，至少一个用户界面模块，至少一个电源模块。通过与至少一个测量引擎模块，至少一个用户接口模块和至少一个电源模块的互连平台的互连来组装手持血糖测试仪器。通过实现从一组可靠性协议中选择的至少一个可靠性协议，连接到其上的模块之间的模块间通信实现增强的葡萄糖测试仪器的可靠性。

10. 发明申请

US20130042117A1 CRYPTOGRAPHIC DATA DISTRIBUTION AND REVOCATION FOR HANDHELD MEDICAL DEVICES 有权
标题翻译：手术医疗器械的CRYPTOGRAPHIC数据分配和撤销
公开(公告)号：US20130042117A1
公开(公告)日：2013-02-14
申请号：US13207934
申请日：2011-08-11
申请人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
发明人： Daniel Birtwhistle , James Tenbarge , Ulrich Porsch , Kai-Oliver Schwenker , Eric Rachner
IPC分类号： G06F21/20
CPC分类号： H04L63/0823 , G06F19/00 , G16H40/40 , H04L9/3268 , H04W12/08 , H04W88/02
摘要： A method includes: receiving a revocation list from a remote data server at a configuration device. The revocation list includes N cryptographic certificates associated with N computer software entities, respectively, that are not to be executed by any of a group of medical devices including a handheld medical device. N is an integer greater than or equal to zero The method further includes receiving data from the handheld medical device at the configuration device. The data includes a cryptographic certificate that is associated with a given computer software entity that is presently installed in memory of the handheld medical device for execution by the handheld medical device. The method further includes comparing the cryptographic certificate with the revocation list; and selectively executing a protective function by the configuration device when the cryptographic certificate is the same as one of the N cryptographic certificates of the revocation list.
摘要翻译：一种方法包括：在配置设备处从远程数据服务器接收撤销列表。撤销列表分别包括与N个计算机软件实体相关联的N个加密证书，其不被包括手持医疗设备的一组医疗设备中的任何一个执行。 N是大于或等于零的整数。该方法还包括在配置设备处从手持式医疗设备接收数据。数据包括与当前安装在手持式医疗设备的存储器中以由手持医疗设备执行的给定计算机软件实体相关联的加密证书。该方法还包括将加密证书与撤销列表进行比较; 并且当密码证书与撤销列表的N个密码证书中的一个相同时，由配置设备选择性地执行保护功能。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式